RPG Life Sciences Limited

BSE:532983 Stock Report

Market Cap: ₹41.8b

RPG Life Sciences Past Earnings Performance

Past criteria checks 3/6

RPG Life Sciences has been growing earnings at an average annual rate of 22.4%, while the Pharmaceuticals industry saw earnings growing at 13.3% annually. Revenues have been growing at an average rate of 12.2% per year. RPG Life Sciences's return on equity is 20.9%, and it has net margins of 12.4%.

Key information

22.4%

Earnings growth rate

22.4%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate12.2%
Return on equity20.9%
Net Margin12.4%
Last Earnings Update31 Dec 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How RPG Life Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:532983 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 246,3737911,4870
30 Sep 246,1837071,5360
30 Jun 245,9979231,5410
31 Mar 245,8218771,5420
31 Dec 235,7368481,5130
30 Sep 235,5057741,4590
30 Jun 235,3177151,4030
31 Mar 235,1286761,3460
31 Dec 224,9816481,2370
30 Sep 224,8316031,2090
30 Jun 224,6105611,1880
31 Mar 224,4025151,1530
31 Dec 214,2915091,0580
30 Sep 214,2114911,0460
30 Jun 214,0564459520
31 Mar 213,8914001,0550
31 Dec 203,8513611,0800
30 Sep 203,7183111,0650
30 Jun 203,7322971,0550
31 Mar 203,7562909930
31 Dec 193,5572761,0100
30 Sep 193,5232491,0080
30 Jun 193,4431739970
31 Mar 193,3021089880
31 Dec 183,4481051,0560
30 Sep 183,4951071,0480
30 Jun 183,4851491,0270
31 Mar 183,4401351,0090
31 Dec 173,3601418700
30 Sep 173,062978330
30 Jun 172,948628010
31 Mar 172,9361218350
31 Dec 163,0292297840
30 Sep 163,0952707890
30 Jun 162,9931947820
31 Mar 162,552846960
31 Dec 152,7581411,0400
30 Sep 152,6091199660
30 Jun 152,501209780
31 Mar 152,423106860
31 Dec 142,290-429280
30 Sep 142,273-981,0190
30 Jun 142,312-16990
31 Mar 142,3565349930

Quality Earnings: 532983 has high quality earnings.

Growing Profit Margin: 532983's current net profit margins (12.4%) are lower than last year (14.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 532983's earnings have grown significantly by 22.4% per year over the past 5 years.

Accelerating Growth: 532983's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 532983 had negative earnings growth (-6.7%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (21%).

Return on Equity

High ROE: 532983's Return on Equity (20.9%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 00:52
End of Day Share Price 2025/02/06 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

RPG Life Sciences Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kunal DhameshaEmkay Global Financial Services Ltd.
Kameswari V. S. ChavaliFirstCall Research